RMST
geneOn this page
Also known as NCRMSNCRNA00054LINC00054
Summary
RMST (rhabdomyosarcoma 2 associated transcript, HGNC:29893) is a long non-coding RNA gene on chromosome 12q23.1.
This gene produces a long non-coding RNA that functions in neurogenesis by aiding in the association of Sox2 transcription factor to its target promoters.
Source: NCBI Gene 196475 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29893 |
| Approved symbol | RMST |
| Name | rhabdomyosarcoma 2 associated transcript |
| Location | 12q23.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NCRMS, NCRNA00054, LINC00054 |
| Ensembl gene | ENSG00000255794 |
| Ensembl biotype | lncRNA |
| OMIM | 607045 |
| Entrez | 196475 |
| RNAcentral | URS00026A1B05 — lncRNA, 2428 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 68 — 65 lncRNA, 3 retained_intron
ENST00000538559, ENST00000541282, ENST00000547946, ENST00000547996, ENST00000548886, ENST00000552411, ENST00000639121, ENST00000639542, ENST00000640149, ENST00000652810, ENST00000654331, ENST00000655366, ENST00000656448, ENST00000656458, ENST00000657936, ENST00000658877, ENST00000660138, ENST00000661686, ENST00000662330, ENST00000662502, ENST00000662772, ENST00000663411, ENST00000663509, ENST00000663659, ENST00000664656, ENST00000664685, ENST00000665975, ENST00000666664, ENST00000666798, ENST00000667306, ENST00000667445, ENST00000670160, ENST00000670745, ENST00000687565, ENST00000687746, ENST00000689144, ENST00000690227, ENST00000690936, ENST00000693044, ENST00000701029, ENST00000774530, ENST00000774531, ENST00000774532, ENST00000774533, ENST00000774534, ENST00000774535, ENST00000774536, ENST00000774537, ENST00000774538, ENST00000774539, ENST00000774540, ENST00000774541, ENST00000774542, ENST00000774543, ENST00000774544, ENST00000774545, ENST00000774546, ENST00000774547, ENST00000774548, ENST00000774549, ENST00000774550, ENST00000774551, ENST00000774552, ENST00000774553, ENST00000774554, ENST00000774555, ENST00000774556, ENST00000850890
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000538559 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002216996 | 97494695 | 97494881 |
| ENSE00002232678 | 97560797 | 97561047 |
| ENSE00002257413 | 97564738 | 97565015 |
| ENSE00002273955 | 97564150 | 97564328 |
| ENSE00002276943 | 97493875 | 97494002 |
| ENSE00002283878 | 97492461 | 97492606 |
| ENSE00002288440 | 97530655 | 97530859 |
| ENSE00002306508 | 97560537 | 97560698 |
| ENSE00002337367 | 97463152 | 97463289 |
| ENSE00002341905 | 97431653 | 97431934 |
| ENSE00002363301 | 97493177 | 97493285 |
| ENSE00002363944 | 97461972 | 97462146 |
| ENSE00002383061 | 97460715 | 97460863 |
| ENSE00002412217 | 97462664 | 97462872 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 99.21.
FANTOM5 (CAGE): breadth broad, TPM avg 8.5003 / max 444.6707, expressed in 428 samples.
FANTOM5 promoters (22 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127497 | 3.4712 | 368 |
| 127498 | 0.9562 | 227 |
| 127510 | 0.7929 | 164 |
| 127501 | 0.6890 | 153 |
| 127500 | 0.5568 | 144 |
| 127502 | 0.4497 | 123 |
| 127511 | 0.2509 | 86 |
| 127513 | 0.1996 | 99 |
| 127499 | 0.1901 | 73 |
| 127512 | 0.1624 | 81 |
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of thyroid gland | UBERON:0001119 | 99.21 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 99.13 | gold quality |
| thyroid gland | UBERON:0002046 | 99.05 | gold quality |
| adenohypophysis | UBERON:0002196 | 97.65 | gold quality |
| right uterine tube | UBERON:0001302 | 97.12 | gold quality |
| pituitary gland | UBERON:0000007 | 97.10 | gold quality |
| corpus callosum | UBERON:0002336 | 95.26 | gold quality |
| hypothalamus | UBERON:0001898 | 90.00 | gold quality |
| prostate gland | UBERON:0002367 | 86.25 | gold quality |
| fallopian tube | UBERON:0003889 | 83.60 | gold quality |
| left uterine tube | UBERON:0001303 | 82.55 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.31 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 79.47 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 78.93 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 78.23 | gold quality |
| right frontal lobe | UBERON:0002810 | 77.69 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 76.61 | gold quality |
| kidney | UBERON:0002113 | 76.17 | gold quality |
| substantia nigra | UBERON:0002038 | 75.82 | gold quality |
| tonsil | UBERON:0002372 | 75.78 | gold quality |
| brain | UBERON:0000955 | 75.51 | gold quality |
| amygdala | UBERON:0001876 | 75.37 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.27 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 75.23 | gold quality |
| temporal lobe | UBERON:0001871 | 75.16 | gold quality |
| cortex of kidney | UBERON:0001225 | 74.97 | gold quality |
| metanephros cortex | UBERON:0010533 | 74.28 | gold quality |
| cerebral cortex | UBERON:0000956 | 74.22 | gold quality |
| bone marrow cell | CL:0002092 | 72.48 | gold quality |
| frontal cortex | UBERON:0001870 | 72.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-25 | yes | 894.19 |
| E-ANND-3 | yes | 7.27 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 11)
- NCRMS is located on chromosome 12q21 (PMID:12082533)
- Single nucleotide polymorphisms in RMST gene is associated with obesity. (PMID:23563609)
- RMST is required for the binding of SOX2 to promoter regions of neurogenic transcription factors. These results establish the role of RMST as a transcriptional coregulator of SOX2 and a key player in the regulation of neural stem cell fate. (PMID:23932716)
- disruption of trans-spliced noncoding RNA RMST expression in human embryonic stem cells results in the upregulation of WNT5A, epithelial-to-mesenchymal transition, and lineage-specific genes/markers. (PMID:27090862)
- Knockdown of RMST Impedes Neuronal Apoptosis and Oxidative Stress in OGD/R-Induced Ischemic Stroke Via Depending on the miR-377/SEMA3A Signal Network. (PMID:33409855)
- Long non-coding RNA RMST promotes oxygen-glucose deprivation-induced injury in brain microvascular endothelial cells by regulating miR-204-5p/VCAM1 axis. (PMID:33607153)
- Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma. (PMID:33866410)
- LncRNA RMST Regulates Neuronal Apoptosis and Inflammatory Response via Sponging miR-150-5p in Parkinson’s Disease. (PMID:34515176)
- Abnormal expression of long non-coding RNA rhabdomyosarcoma 2-associated transcript (RMST) participates in the pathological mechanism of atherosclerosis by regulating miR-224-3p. (PMID:35067166)
- Long non-coding RNA RMST serves as a diagnostic biomarker in patients with carotid artery stenosis and predicts the occurrence of cerebral ischemic event: A retrospective study. (PMID:35531613)
- lncRNA RMST suppresses the progression of colorectal cancer by competitively binding to miR-27a-3p/RXRalpha axis and inactivating Wnt signaling pathway. (PMID:37246895)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Kawasaki disease, obstructive sleep apnea syndrome